{"transactions":[{"id":4623265,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69511,"kind":"person","name":"NEUGEBOREN EDWARD","position":1,"cik":"0001320873","reported_name":"NEUGEBOREN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-21T20:22:31.000Z","date":"2026-09-17","kind":"grant","planned":false,"acquired":true,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of this option vests on the date of grant and the remaining 50% vests in substantially equal monthly installments over a 12-month period, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":12200,"derivative":{"exercise_price":2.13,"expiration_date":"2036-09-16","underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0001140361-26-037246","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126037246/form4.xml","form_type":"4"}},{"id":940924,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69511,"kind":"person","name":"NEUGEBOREN EDWARD","position":1,"cik":"0001320873","reported_name":"NEUGEBOREN EDWARD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T21:01:34.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on the date of grant and the remaining 75% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2026, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":3.8,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-26-000967","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126000967/form4.xml","form_type":"4"}},{"id":1150749,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69511,"kind":"person","name":"NEUGEBOREN EDWARD","position":1,"cik":"0001320873","reported_name":"NEUGEBOREN EDWARD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-13T21:21:14.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of this option vests on the date of grant and the remaining 50% vests in substantially equal monthly installments on the 30th day of each month until September 30, 2025, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":2.72,"expiration_date":"2035-05-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-25-018696","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036125018696/form4.xml","form_type":"4"}},{"id":1160853,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":69511,"kind":"person","name":"NEUGEBOREN EDWARD","position":1,"cik":"0001320873","reported_name":"NEUGEBOREN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to Buy)","published_at":"2025-05-02T17:19:50.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":11600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made subject to the approval of, and in accordance with the terms of, the Issuer's 2025 Equity Incentive Plan (the \"2025 Plan\"), which will be voted on at the Issuer's 2025 annual meeting of stockholders to be held on June 23, 2025. 100% of the options vest, subject to stockholder approval of the 2025 Plan, on April 30, 2026."}],"balance_after":11600,"derivative":{"exercise_price":0.59,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":11600},"source":{"system":"sec-edgar","filing":"0001641172-25-008426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1320873/000164117225008426/ownership.xml","form_type":"4"}},{"id":1703284,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":69511,"kind":"person","name":"NEUGEBOREN EDWARD","position":1,"cik":"0001320873","reported_name":"NEUGEBOREN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-20T21:06:54.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which 10,000 shares vest in equal monthly installments over a period of 12 months (provided that 3/12 of the options shall be deemed to have vested upon the date of grant), and 12,500 shares vest in equal quarterly installments over a period of 18 months (Provided that 1/6 of the options shall be deemed to have vested upon the date of grant)."}],"balance_after":22500,"derivative":{"exercise_price":2.125,"expiration_date":"2033-12-19","underlying":"Class A Common Shares","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-23-071879","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000095017023071879/ownership.xml","form_type":"4"}}]}